Literature DB >> 24622638

Trends in HIV diagnoses, HIV care, and uptake of antiretroviral therapy among heterosexual adults in England, Wales, and Northern Ireland.

Brian Rice1, Jonathan Elford, Zheng Yin, Sara Croxford, Alison Brown, Valerie Delpech.   

Abstract

AIM: To examine epidemiological trends among heterosexual adults (≥15 years) in England, Wales, and Northern Ireland (E,W&NI) newly diagnosed as having HIV between 1992 and 2011, or seen for HIV care in 2011.
METHODS: Trend analyses of heterosexual adults newly diagnosed as having HIV in E,W&NI in 1992 to 2011 was performed, as well as univariate and multivariate analyses examining the late diagnosis of HIV, integration into care, AIDS, uptake of antiretroviral therapy, and mortality in 2002 to 2011. Data are as reported to the national HIV and AIDS Reporting System.
RESULTS: The number of heterosexual adults newly diagnosed as having HIV in E,W&amp;NI increased steadily between 1992 (731) and 2004 (4676), before declining (2631 in 2011). Nonetheless, in 2011, heterosexuals accounted for 49% (2631/5423) of all newly diagnosed adults in E,W&amp;NI. Of 38,228 heterosexual adults as having HIV between 2002 and 2011, 72% were black African, of whom 99% were born abroad. Over the decade, there was an increase in the percentage of HIV diagnosed heterosexuals integrated into care within 28 days of diagnosis (61%-78%) and in receipt of antiretroviral therapy within 1 year of diagnosis (45%-52%) and a decline in the percentage with AIDS (16%-7%; all, P < 0.01). Late HIV diagnoses (CD4 <350 mm) among heterosexuals exceeded 60% in all years.
CONCLUSIONS: Our analyses highlight the impact of migration on the epidemiology of heterosexually acquired HIV in E,W&amp;NI. Although there was evidence of an improvement in clinical care over time, continued high rates of late diagnosis suggest that current testing policies are failing among heterosexuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622638     DOI: 10.1097/OLQ.0000000000000111

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

1.  Diagnosis delays in the UK according to pre or postmigration acquisition of HIV.

Authors:  Oliver Stirrup; Anna Tostevin; Manon Ragonnet-Cronin; Erik Volz; Fiona Burns; Valerie Delpech; David Dunn
Journal:  AIDS       Date:  2022-03-01       Impact factor: 4.632

2.  Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in Australia.

Authors:  Ye Zhang; Virginia Wiseman; Tanya L Applegate; Richard De Abreu Lourenco; Deborah J Street; Kirsty Smith; Muhammad S Jamil; Fern Terris-Prestholt; Christopher K Fairley; Anna McNulty; Adam Hynes; Karl Johnson; Eric P F Chow; Benjamin R Bavinton; Andrew Grulich; Mark Stoove; Martin Holt; John Kaldor; Rebecca Guy; Jason J Ong
Journal:  Front Med (Lausanne)       Date:  2022-04-19

3.  Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity.

Authors:  Rageshri Dhairyawan; Hajra Okhai; Teresa Hill; Caroline A Sabin
Journal:  AIDS       Date:  2021-09-01       Impact factor: 4.177

Review 4.  A systematic review of post-migration acquisition of HIV among migrants from countries with generalised HIV epidemics living in Europe: mplications for effectively managing HIV prevention programmes and policy.

Authors:  Ibidun Fakoya; Débora Álvarez-del Arco; Melvina Woode-Owusu; Susana Monge; Yaiza Rivero-Montesdeoca; Valerie Delpech; Brian Rice; Teymur Noori; Anastasia Pharris; Andrew J Amato-Gauci; Julia del Amo; Fiona M Burns
Journal:  BMC Public Health       Date:  2015-06-19       Impact factor: 3.295

5.  Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort.

Authors:  Eline L M Op de Coul; Ard van Sighem; Kees Brinkman; Birgit H van Benthem; Marchina E van der Ende; Suzanne Geerlings; Peter Reiss
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

6.  Ultra-rapid, sensitive and specific digital diagnosis of HIV with a dual-channel SAW biosensor in a pilot clinical study.

Authors:  Eleanor R Gray; Valérian Turbé; Victoria E Lawson; Robin H Page; Zara C Cook; R Bridget Ferns; Eleni Nastouli; Deenan Pillay; Hiromi Yatsuda; Dale Athey; Rachel A McKendry
Journal:  NPJ Digit Med       Date:  2018-08-17

7.  HIV diagnoses in migrant populations in Australia-A changing epidemiology.

Authors:  Praveena Gunaratnam; Anita Elizabeth Heywood; Skye McGregor; Muhammad Shahid Jamil; Hamish McManus; Limin Mao; Roanna Lobo; Graham Brown; Margaret Hellard; Tafireyi Marukutira; Neil Arvin Bretaña; Carolyn Lang; Nicholas Medland; Benjamin Bavinton; Andrew Grulich; Rebecca Guy
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

8.  Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study.

Authors:  Juan M Leyva-Moral; Blanca K Loayza-Enriquez; Patrick A Palmieri; Genesis M Guevara-Vasquez; Ursula E Elias-Bravo; Joan E Edwards; María Feijoo-Cid; Lucy Y Davila-Olano; Juan R Rodriguez-Llanos; Franco E Leon-Jimenez
Journal:  AIDS Res Ther       Date:  2019-08-28       Impact factor: 2.250

9.  Identifying risk factors for late HIV diagnosis and survival analysis of people living with HIV/AIDS in Iran (1987-2016).

Authors:  Younes Mohammadi; Mohammad Mirzaei; Nasrin Shirmohammadi-Khorram; Maryam Farhadian
Journal:  BMC Infect Dis       Date:  2021-04-27       Impact factor: 3.090

10.  Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets: A retrospective observational study.

Authors:  Tafireyi Marukutira; Praveena Gunaratnam; Caitlin Douglass; Muhammad S Jamil; Skye McGregor; Rebecca Guy; Richard Thomas Gray; Tim Spelman; Danielle Horyniak; Nasra Higgins; Carolien Giele; Suzanne Mary Crowe; Mark Stoove; Margaret Hellard
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.